Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Active Rheumatoid Arthritis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02480153
What this trial is testing

PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02).

Who this might be right for
Rheumatoid Arthritis
Pfizer 597
Post-approval studies (Phase 4)Study completedNCT01185288
What this trial is testing

Determine the Effect of Methotrexate (MTX) Dose on Clinical Outcome and Ultrasonographic Signs in Subjects With Moderately to Severely Active Rheumatoid Arthritis (RA) Treated With Adalimumab (MUSICA)

Who this might be right for
Rheumatoid Arthritis
AbbVie (prior sponsor, Abbott) 309
Testing effectiveness (Phase 2)Ended earlyNCT02862574
What this trial is testing

Andecaliximab as Add-On Therapy to a Tumor Necrosis Factor Inhibitor and Methotrexate Regimen in Adults With Moderately to Severely Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Gilead Sciences 15
Large-scale testing (Phase 3)Study completedNCT03478111
What this trial is testing

CMAB008 With MTX Therapy in Adult Patients With Moderately to Severely Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Shanghai Biomabs Pharmaceutical Co., Ltd. 390
Large-scale testing (Phase 3)Study completedNCT01721044
What this trial is testing

A Moderate to Severe Rheumatoid Arthritis Study

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 527
Early research (Phase 1)Looking for participantsNCT07041099
What this trial is testing

CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease

Who this might be right for
SjögrenSjogren DiseaseSjogren's Syndrome
Cullinan Therapeutics Inc. 36
Testing effectiveness (Phase 2)Study completedNCT02065700
What this trial is testing

Long-term Follow-up Study of GLPG0634 in Active Rheumatoid Arthritis Participants

Who this might be right for
Rheumatoid Arthritis
Lakefront Biotherapeutics NV 739
Testing effectiveness (Phase 2)Ended earlyNCT06859294
What this trial is testing

LY3541860 in Adult Participants With Moderately to Severely Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 35
Large-scale testing (Phase 3)Study completedNCT01951170
What this trial is testing

An Open-Label Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 52
Testing effectiveness (Phase 2)Looking for participantsNCT07408024
What this trial is testing

Safety and Efficacy of TollB-001 Tablets in Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis (RA)
Toll Biotech Co. Ltd. (Beijing) 24
Post-approval studies (Phase 4)Study completedNCT01089023
What this trial is testing

Tocilizumab as Monotherapy or in Combination With DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 95
Large-scale testing (Phase 3)Study completedNCT04333771
What this trial is testing

Evaluate the Efficacy and Safety of SHR0302 in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Jiangsu HengRui Medicine Co., Ltd. 566
Very early researchNot Yet RecruitingNCT06982547
What this trial is testing

Clinical Study on the Treatment of Refractory Rheumatoid Arthritis With UTAA91 Injection

Who this might be right for
Rheumatoid Arthritis (RA)
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 24
Testing effectiveness (Phase 2)Study completedNCT01404585
What this trial is testing

Proof-of-Concept Study With BMS-817399 to Treat Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Bristol-Myers Squibb 123
Large-scale testing (Phase 3)Study completedNCT03789292
What this trial is testing

Compare Efficacy and Safety of CT-P17 With Humira in Patients With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Celltrion 648
Early research (Phase 1)Ended earlyNCT06087406
What this trial is testing

A Phase 1b Study of Imvotamab in Moderate to Severe Rheumatoid Arthritis

Who this might be right for
Rheumatoid ArthritisArthritis, RheumatoidArthritis
IGM Biosciences, Inc. 33
Testing effectiveness (Phase 2)Study completedNCT04634253
What this trial is testing

LY3462817 in Participants With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Eli Lilly and Company 98
Large-scale testing (Phase 3)Ended earlyNCT03970837
What this trial is testing

Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs)

Who this might be right for
Arthritis, Rheumatoid
GlaxoSmithKline 1,764
Post-approval studies (Phase 4)Study completedNCT02187055
What this trial is testing

An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate

Who this might be right for
Rhematoid Arthritis
Pfizer 1,152
Testing effectiveness (Phase 2)Active Not RecruitingNCT07233655
What this trial is testing

A Phase II Trial of SHR-3045 Injection in Patients With Rheumatoid Arthritis

Who this might be right for
Moderate to Severe Active Rheumatoid Arthritis
Guangdong Hengrui Pharmaceutical Co., Ltd 30
Next Page